Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry.

[1]  K. Winters,et al.  The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects , 2010, European Journal of Clinical Pharmacology.

[2]  G. Stone,et al.  Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2009, Journal of the American College of Cardiology.

[3]  Takeshi Kimura,et al.  Clopidogrel resistance in Japanese patients scheduled for percutaneous coronary intervention. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[4]  Michael Weis,et al.  Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. , 2008, European heart journal.

[5]  J. Tardif,et al.  Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study. , 2008, Journal of the American College of Cardiology.

[6]  S. Steinhubl,et al.  Platelet function monitoring in patients with coronary artery disease. , 2007, Journal of the American College of Cardiology.

[7]  G. Biondi-Zoccai,et al.  Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention. , 2007, The American journal of cardiology.

[8]  A. Gori,et al.  Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. , 2007, Journal of the American College of Cardiology.

[9]  Harald Langer,et al.  Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. , 2006, European heart journal.

[10]  P. Gurbel,et al.  Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study. , 2005, Journal of the American College of Cardiology.

[11]  R. D'Agostino.  Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .

[12]  V. Pasceri,et al.  Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study* , 2005, Circulation.

[13]  Deepak L. Bhatt,et al.  Variability in platelet responsiveness to clopidogrel among 544 individuals. , 2005, Journal of the American College of Cardiology.

[14]  R. Severino,et al.  Mortality rates and hemorrhagic complications in asian-pacific islanders during treatment of acute myocardial infarction. , 2004, The American journal of cardiology.

[15]  Kevin P. Bliden,et al.  Clopidogrel for Coronary Stenting Response Variability, Drug Resistance, and the Effect of Pretreatment Platelet Reactivity , 2003, Circulation.

[16]  M. Seyfarth,et al.  Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement. , 2001, The American journal of cardiology.

[17]  K. Mahaffey,et al.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation , 2012 .

[18]  P. Morange,et al.  FOCUS ISSUE: CARDIAC INTERVENTION Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary Stenting , 2006 .